No More Needles: Canada Approves a Nasal Spray to Treat Severe Allergic Reactions
Health Canada approves neffy®, a needle-free epinephrine nasal spray for anaphylaxis. Learn how it works and when it’s coming to Canada.
Health Canada Warns: Think Twice Before Injecting Peptides Bought Online
Health Canada warns against unapproved peptide injections trending online for weight loss and anti-aging, citing serious health risks and lack of regulation.
GLP-1s and Bone Health: Potential Risks for Non-Diabetics
New studies reveal a 22% higher osteoporosis risk for non-diabetics on GLP-1s. Learn how these weight-loss drugs may impact your skeletal strength.
Kidney Breakthrough: Health Canada Authorizes First-of-its-Kind Treatment for Lupus Nephritis
Health Canada authorizes Gazyva for lupus nephritis. Discover how this twice-yearly treatment improves kidney response and prevents failure.
New Study Warns of Rapid Weight Regain When Quitting Weight Loss Drugs
New research shows stopping weight loss medication leads to rapid regain, with many returning to their original weight in less than two years.
Does HRT Increase Dementia Risk? New 1M Woman Study
A study of 1M women finds HRT doesn't increase dementia risk. We dive into the findings and why women are still more likely to face Alzheimer's.
Health Canada Authorizes First 8-Week Treatment for Acute Hepatitis C
Health Canada’s approval of MAVIRET for acute HCV allows doctors to treat adults and children immediately, a key step toward the 2030 elimination goal.
Health Canada Authorizes TNKase for Treatment of Adult Stroke
Health Canada officially authorizes TNKase for treating acute ischemic stroke in adults. This pivotal approval introduces a faster, 5-second injection to emergency rooms nationwide.
Generic Ozempic: Canada to See Significant Price Drops
Struggling with high medication costs? Generic Ozempic is coming to Canada in 2026. Learn how prices could drop from $400 to around $100.
Wegovy Authorized as Canada’s First Liver Disease Drug
No more "watchful waiting." Health Canada’s approval of Wegovy gives MASH patients their first tangible medical option to fight liver fibrosis.
Canada Authorizes First-Ever Oral Treatment for Postpartum Depression
Canada approves ZURZUVAE, the first oral PPD pill. This breakthrough 14-day oral therapy aims to elevate the standard of maternal mental health care.
Ozempic, Wegovy and Mounjaro Are Changing Our Food Choices
Appetite-suppressing GLP-1 medications may be changing the way Canadians eat – Smaller appetites and healthier choices are impacting restaurants and the food supply sector in significant ways.